Literature DB >> 3195577

Use of a silicone catheter with a Dacron cuff for dialysis short-term vascular access.

A H Moss1, M M McLaughlin, K D Lempert, J L Holley.   

Abstract

Polyurethane and Teflon subclavian vein catheters have been widely used for temporary vascular access for hemodialysis, but their use has been associated with a significant complication rate. A silicone dual-lumen catheter with a Dacron cuff placed in the internal jugular or subclavian vein was evaluated as a means of obtaining short-term vascular access. Sixty-two catheters in 54 patients provided a cumulative experience of 206 patient-months. Blood flow rates greater than or equal to 200 mL/min were achieved, with a mean recirculation of 2.1%. Catheter function was better with placement on the right side. Exit-site infections developed in nine patients, for a rate of 5.3 episodes per 100 patient-months; all resolved with antibiotics. Catheter-related bacteremia occurred in one patient, for a rate of 0.49 episodes per 100 patient-months, a rate much lower than rates reported for polyurethane and Teflon catheters. Clotting occurred in 24.5% of catheters, and thrombolytic therapy was always successful in restoring function. Because of the lower rate of complications, the silicone dual-lumen catheter with a Dacron cuff provides a safer alternative for short-term hemodialysis vascular access than the Teflon and polyurethane catheters.

Entities:  

Mesh:

Year:  1988        PMID: 3195577     DOI: 10.1016/s0272-6386(88)80100-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

1.  Clinical and Regulatory Considerations for Central Venous Catheters for Hemodialysis.

Authors:  Douglas M Silverstein; Scott O Trerotola; Timothy Clark; Garth James; Wing Ng; Amy Dwyer; Marius C Florescu; Roman Shingarev; Stephen R Ash
Journal:  Clin J Am Soc Nephrol       Date:  2018-10-11       Impact factor: 8.237

2.  Reduced patency in left-sided arteriovenous grafts in a porcine model.

Authors:  Shirley Liu; Tun Wang; Juan Wang; Toshihiko Isaji; Shun Ono; Arash Fereydooni; Ryosuke Taniguchi; Yutaka Matsubara; Laura E Niklason; Alan Dardik
Journal:  J Vasc Surg       Date:  2019-11-04       Impact factor: 4.268

3.  Fistula First Initiative: Historical Impact on Vascular Access Practice Patterns and Influence on Future Vascular Access Care.

Authors:  Timmy Lee
Journal:  Cardiovasc Eng Technol       Date:  2017-07-10       Impact factor: 2.495

4.  Safety and Complications of Double-Lumen Tunnelled Cuffed Central Venous Dialysis Catheters: Clinical and radiological perspective from a tertiary centre in Oman.

Authors:  Rana S Hamid; Anupam K Kakaria; Saif A Khan; Saja Mohammed; Rashid Al-Sukaiti; Dawood Al-Riyami; Yasser W Al-Mula Abed
Journal:  Sultan Qaboos Univ Med J       Date:  2015-11-23

5.  Single center review of femoral arteriovenous grafts for hemodialysis.

Authors:  Michael J Englesbe; Wajd N Al-Holou; Alice T Moyer; Jessica Robbins; Shawn J Pelletier; John Magee; Randall S Sung; Darrell Campbell; Jeffery D Punch
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

Review 6.  Administration of chemotherapeutic agents. Techniques and controversies.

Authors:  J H Raaf
Journal:  Support Care Cancer       Date:  1994-11       Impact factor: 3.603

7.  External jugular vein catheterization using 'intra-atrial electrocardiogram'.

Authors:  Dilek Karaaslan; Ugur Altinisik; Tulay Tuncer Peker; Esra Nayir; Sadik Ozmen
Journal:  Yonsei Med J       Date:  2009-04-30       Impact factor: 2.759

8.  Impact of surface topography on biofilm formation by Candida albicans.

Authors:  Katherine Lagree; Htwe H Mon; Aaron P Mitchell; William A Ducker
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

9.  Comparison of treatment delay associated with tunneled hemodialysis catheter placement between interventionists.

Authors:  Yoo Hyung Kim; Hae Ri Kim; Hong Jae Jeon; Ye-Jin Kim; Sa Ra Jung; Dae Eun Choi; Kang Wook Lee; Ki Ryang Na
Journal:  Korean J Intern Med       Date:  2016-04-14       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.